☰

Skip to content

Home
Studies
Study Group
Publications
News
Deltagare / Participants

Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts.

2026

Front Aging Neurosci. 2026 Apr 15;18:1766448. doi: 10.3389/fnagi.2026.1766448. eCollection 2026.PMID: 42063624

Rafiee Z, Santiago J, Andersson E, Hansson O, Wennström M.

Front Aging Neurosci. 2026 Apr 15;18:1766448. doi: 10.3389/fnagi.2026.1766448. eCollection 2026.PMID: 42063624

2026 Clinical staging in Swedish primary care using the Amsterdam Instrumental Activities of Daily Living Questionnaire.
2026 Comparability of Centiloid values from [18F]flutemetamol scans using seven commercial and research software
2026 Neuropathological correlates of age and sex differences in 18F-flortaucipir PET.
2026 Amyloid beta pathology induces astrocytic pTDP-43 mislocalization and disrupts TDP-43-regulated cryptic exon transcripts.
2026 Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum.
2026 Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
2026 Free Sugar Intake and Dementia Risk: A Swedish Cohort Study on Dietary Sources and Dementia Subtypes.
2026 A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
2026 Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease.
2026 Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
2026 Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer’s disease: a prospective cohort study
2026 Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
2026 Von Economo Neuron Loss in Frontotemporal Dementia: A Meta-Analysis of Neuropathological Studies
2026 APOE isotype-dependent regulation of IgG and IgA levels against different IAPP epitopes.
2026 Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Follow us

Search for: